umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Patologi.
Umeå universitet, Teknisk-naturvetenskapliga fakulteten, Institutionen för matematik och matematisk statistik.
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Patologi.
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Patologi.
Vise andre og tillknytning
2019 (engelsk)Inngår i: Molecular Oncology, ISSN 1574-7891, E-ISSN 1878-0261, Vol. 13, nr 8, s. 1763-1777Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Bone metastasis is the lethal end-stage of prostate cancer (PC), but the biology of bone metastases is poorly understood. The overall aim of this study was therefore to explore molecular variability in PC bone metastases of potential importance for therapy. Specifically, genome-wide expression profiles of bone metastases from untreated patients (n = 12) and patients treated with androgen-deprivation therapy (ADT, n = 60) were analyzed in relation to patient outcome and to morphological characteristics in metastases and paired primary tumors. Principal component analysis and unsupervised classification were used to identify sample clusters based on mRNA profiles. Clusters were characterized by gene set enrichment analysis and related to histological and clinical parameters using univariate and multivariate statistics. Selected proteins were analyzed by immunohistochemistry in metastases and matched primary tumors (n = 52) and in transurethral resected prostate (TUR-P) tissue of a separate cohort (n = 59). Three molecular subtypes of bone metastases (MetA-C) characterized by differences in gene expression pattern, morphology, and clinical behavior were identified. MetA (71% of the cases) showed increased expression of androgen receptor-regulated genes, including prostate-specific antigen (PSA), and glandular structures indicating a luminal cell phenotype. MetB (17%) showed expression profiles related to cell cycle activity and DNA damage, and a pronounced cellular atypia. MetC (12%) exhibited enriched stroma-epithelial cell interactions. MetB patients had the lowest serum PSA levels and the poorest prognosis after ADT. Combined analysis of PSA and Ki67 immunoreactivity (proliferation) in bone metastases, paired primary tumors, and TUR-P samples was able to differentiate MetA-like (high PSA, low Ki67) from MetB-like (low PSA, high Ki67) tumors and demonstrate their different prognosis. In conclusion, bone metastases from PC patients are separated based on gene expression profiles into molecular subtypes with different morphology, biology, and clinical outcome. These findings deserve further exploration with the purpose of improving treatment of metastatic PC.

sted, utgiver, år, opplag, sider
John Wiley & Sons, 2019. Vol. 13, nr 8, s. 1763-1777
Emneord [en]
bone metastasis, gene expression, gene set enrichment analysis, morphology, survival, unsupervised cluster analysis
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-162668DOI: 10.1002/1878-0261.12526ISI: 000478600200009PubMedID: 31162796OAI: oai:DiVA.org:umu-162668DiVA, id: diva2:1348763
Tilgjengelig fra: 2019-09-05 Laget: 2019-09-05 Sist oppdatert: 2019-09-05bibliografisk kontrollert

Open Access i DiVA

fulltext(2287 kB)57 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 2287 kBChecksum SHA-512
d1f2014331f65d4e75ec7f71e7227fc2b8eb57b54e26b2edbd951f2d47be3e4a5973e2cd17eaa9c15ba87ddf663270be4598297b1202ae77af972aef9869b867
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Thysell, ElinVidman, LindaBovinder Ylitalo, ErikJernberg, EmmaCrnalic, SeadWidmark, AndersRydén, PatrikBergh, AndersWikström, Pernilla

Søk i DiVA

Av forfatter/redaktør
Thysell, ElinVidman, LindaBovinder Ylitalo, ErikJernberg, EmmaCrnalic, SeadWidmark, AndersRydén, PatrikBergh, AndersWikström, Pernilla
Av organisasjonen
I samme tidsskrift
Molecular Oncology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 57 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 157 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf